Metformin and Vildagliptin Combination: A New Approach of Endothelial Nitric Oxide Synthase Activity Regulation and Metabolism in Diabetes Mellitus Type 2

Reviews on Clinical Pharmacology and Drug Therapy
doi 10.17816/rcf1625-12

Related search